References

  1. Mortality GBD and C. Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963): 117-71. Google Scholar

  2. Ferlay J et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 201 Int J Cancer. 2015;136(5):E359-86. PubMed | Google Scholar

  3. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20(4):992-1000. PubMed | Google Scholar

  4. Shimakawa Y et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia. Gut. 2016;65(12): 2007-2016. PubMed | Google Scholar

  5. Casey RM et al. Global Routine Vaccination Coverage, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(45):1270-1273. PubMed | Google Scholar

  6. Decker MD. Principles of pediatric combination vaccines and practical issues related to use in clinical practice. Pediatr Infect Dis J. 2001;20(11 Suppl):S10-8. PubMed | Google Scholar

  7. Andersson MI et al. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine. 2013;31(47):5579-84. PubMed | Google Scholar

  8. Sangare L et al. Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull Soc Pathol Exot. 2009;102(4):226-9. PubMed | Google Scholar

  9. Chasela CS et al. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol. 2014;60(3):508-14. PubMed | Google Scholar

  10. Chotun N et al. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine. 2015 Aug 26;33(36):4618-22. PubMed | Google Scholar

  11. Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005-1017. PubMed | Google Scholar

  12. Organization WH. WHO guidelines on hepatitis B and C testing. 2017, WHO: Geneva. Google Scholar

  13. Sellier PO et al. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. Eur J Gastroenterol Hepatol. 2017;29(3):259-263. PubMed | Google Scholar

  14. Pan CQ et al. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. N Engl J Med. 2016;374(24):2324-34. PubMed | Google Scholar

  15. Loriette M et al. An experience of hepatitis B control in a rural area in Far North Cameroon. Med Santé Trop. 2015;25(4):422-7. PubMed | Google Scholar

  16. Klingler C, Thoumi AI, Mrithinjayam VS. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. Vaccine. 2012;31(1):252-9. PubMed | Google Scholar

  17. Lemoine M et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4(8):e559-67. PubMed | Google Scholar

  18. Nayagam S et al. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis. Lancet Glob Health. 2016;4(8):e568-78. PubMed | Google Scholar

  19. (WHO), W.H.O., Practices to improve coverage of the hepatitis B birth dose vaccine. 2012: Geneva, Switzerland. Google Scholar

  20. Program, T.D., DHS Survey Indicators - Maternal and Child Health. 2015. Google Scholar

  21. Kolwaite AR et al. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR. Vaccine. 2016;34(28):3324-30. PubMed | Google Scholar